Cellectar Biosciences Inc (CLRB)
3.30
-0.03
(-0.90%)
USD |
NASDAQ |
May 17, 16:00
3.295
0.00 (0.00%)
After-Hours: 20:00
Cellectar Biosciences Shares Outstanding: 35.85M for May 8, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
| Date | Value |
|---|---|
| May 08, 2024 | 35.85M |
| April 24, 2024 | 35.85M |
| March 31, 2024 | 33.16M |
| March 21, 2024 | 32.26M |
| December 31, 2023 | 20.74M |
| November 10, 2023 | 12.29M |
| October 04, 2023 | 9.943M |
| September 30, 2023 | 9.918M |
| September 26, 2023 | 9.918M |
| September 15, 2023 | 9.918M |
| August 09, 2023 | 9.740M |
| June 30, 2023 | 9.740M |
| May 02, 2023 | 9.740M |
| April 25, 2023 | 9.740M |
| March 31, 2023 | 9.740M |
| March 03, 2023 | 9.740M |
| December 31, 2022 | 9.385M |
| October 31, 2022 | 9.385M |
| October 25, 2022 | 9.385M |
| October 19, 2022 | 6.110M |
| September 30, 2022 | 6.110M |
| August 02, 2022 | 6.110M |
| July 22, 2022 | 6.110M |
| June 30, 2022 | 6.110M |
| May 06, 2022 | 6.110M |
| Date | Value |
|---|---|
| April 26, 2022 | 6.110M |
| April 14, 2022 | 6.110M |
| March 31, 2022 | 6.110M |
| March 18, 2022 | 6.110M |
| December 31, 2021 | 6.110M |
| November 08, 2021 | 6.110M |
| November 05, 2021 | 6.110M |
| September 30, 2021 | 6.110M |
| August 04, 2021 | 6.110M |
| June 30, 2021 | 5.527M |
| May 05, 2021 | 5.273M |
| April 26, 2021 | 5.273M |
| March 31, 2021 | 5.273M |
| March 01, 2021 | 5.050M |
| February 01, 2021 | 4.545M |
| January 21, 2021 | 4.545M |
| January 15, 2021 | 4.545M |
| January 04, 2021 | 4.544M |
| December 31, 2020 | 4.544M |
| December 28, 2020 | 4.541M |
| December 22, 2020 | 2.726M |
| December 21, 2020 | 2.726M |
| November 09, 2020 | 2.681M |
| November 04, 2020 | 2.681M |
| September 30, 2020 | 2.681M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
0.9387M
Minimum
Jun 30 2019
35.85M
Maximum
Apr 24 2024
7.321M
Average
6.110M
Median
Aug 04 2021
Shares Outstanding Benchmarks
| Perspective Therapeutics Inc | 622.63M |
| Eli Lilly and Co | 950.41M |
| Actinium Pharmaceuticals Inc | 29.78M |
| Bristol-Myers Squibb Co | 2.027B |
| Altimmune Inc | 70.90M |